Prolonged allograft ischemic time is not associated with higher incidence of antibody-mediated rejection.
Singhal
Arun K
AK
Drakos
Stavros G
SG
Kfoury
Abdallah G
AG
Horne
Benjamin D
BD
Verma
Divya Ratan
DR
Stehlik
Josef
J
D000328:Adult; D000906:Antibodies / Q000097:blood; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology*; D016027:Heart Transplantation / Q000379:methods*; D006801:Humans; D015994:Incidence; D015428:Myocardial Reperfusion Injury; D012189:Retrospective Studies; D013997:Time Factors; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D000906:Antibodies